Search Results - "Bouchahda, M"

Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer by Dulong, S., Huang, Q., Innominato, P. F., Karaboue, A., Bouchahda, M., Pruvost, A., Théodoro, F., Agrofoglio, L. A., Adam, R., Finkenstädt, B., Lévi, F.

“…Urinary levels of modified nucleosides reflect nucleic acids turnover and can serve as non-invasive biomarkers for monitoring tumour circadian dynamics, and…”
Get full text

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV by Lévi, F.A., Boige, V., Hebbar, M., Smith, D., Lepère, C., Focan, C., Karaboué, A., Guimbaud, R., Carvalho, C., Tumolo, S., Innominato, P., Ajavon, Y., Truant, S., Castaing, D., De Baere, T., Kunstlinger, F., Bouchahda, M., Afshar, M., Rougier, P., Adam, R., Ducreux, M.

“…Systemic chemotherapy typically converts previously unresectable liver metastases (LM) from colorectal cancer to curative intent resection in ∼15% of patients…”
Get full text

Modern insights into hepatic arterial infusion for liver metastases from colorectal cancer by Bouchahda, M, Lévi, F, Adam, R, Rougier, P

“…Abstract Hepatic arterial infusion (HAI) selectively achieves high drug exposure of liver metastases from colorectal cancer. Such pharmacologic advantage has…”
Get full text

2058 Early tumor shrinkage as a predictor for long-term outcome in patients (pts) with unresectable liver metastases from wt-KRAS colorectal cancer (LM-CRC) treated with hepatic artery infusion (HAI) of Irinotecan, 5-Fluorouracil and Oxaliplatin plus intravenous Cetuximab (IV-Cet) after failure of one to three systemic protocols (European phase II clinical trial NCT00852228) by Bouchahda, M, Michel, D, Denis, S, Abdoulaye, K, Mohamed, H, Celine, L, Christian, F, Rosine, G, Pasquale, I, Sameh, A, Carlos, C, Salvatore, T, Stephanie, T, Thierry, D.B, Denis, C, Philippe, R, Valerie, B, Francois, M. Jean, Rene, A, Francis, L

Get full text

Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer by Bouchahda, M, Macarulla, T, Spano, J.P, Bachet, J.B, Lledo, G, Andre, T, Landi, B, Tabernero, J, Karaboué, A, Domont, J, Levi, F, Rougier, P

“…Abstract Background Few data are available from clinical trials for elderly patients receiving cetuximab. Patients and methods The clinical data of consecutive…”
Get full text

Integrated management of mother and child health in the region of Monastir (Tunisia) by Soltani, M S, El Mhamdi, S, Sriha, A, Bouanene, I, Bouchahda, I, Bouchahda, M

“…The programme of integrated management of child health (IMCI) was established in Tunisia in 2002 in some health districts. This study evaluated the management…”
Get full text

Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis by Bouchahda, M., Macarulla, T., LIedo, G., Lévi, F., Elez, M. E., Paule, B., Karaboué, A., Artru, P., Tabernero, J., Machover, D., Innominato, P., Goldschmidt, E., Bonnet, D., Ducreux, M., Castagne, V., Guimbaud, R.

“…Cetuximab was approved using a weekly schedule, alone or in combination with chemotherapy (CT). However, many CT regimens in metastatic colorectal cancer (CRC)…”
Get full text

Impact of preoperative systemic chemotherapy on liver histology and outcome of hepatic resection for colorectal cancer liver metastases (CRLM) by Adam, R., Sebagh, M., Plasse, M., Karam, V., Giachetti, S., Azoulay, D., Bouchahda, M., Jasmin, C., Castaing, D., Lévi, F.

“…Abstract only…”
Get full text

592P - Undetectable RAS mutant clones in plasma: Possible implication for therapy and prognosis in the patient with RAS mutant metastatic colorectal cancer? by Bouchahda, M., Karaboué, A., Saffroy, R., Hamelin, J., Bosselut, N., Lemoine, A.

“…Combining Cetuximab with chemotherapeutic cytotoxic drugs provides clinical benefit to patients with RAS wild type (RAS-wt) locally advanced or metastatic…”
Get full text

592PUndetectable RAS mutant clones in plasma: Possible implication for therapy and prognosis in the patient with RAS mutant metastatic colorectal cancer? by Bouchahda, M, Karaboué, A, Saffroy, R, Hamelin, J, Bosselut, N, Lemoine, A

“…Abstract Background Combining Cetuximab with chemotherapeutic cytotoxic drugs provides clinical benefit to patients with RAS wild type (RAS-wt) locally…”
Get full text

Undetectable RAS mutant clones in plasma: Possible implication for therapy and prognosis in the patient with RAS mutant metastatic colorectal cancer? by Bouchahda, M., Karaboué, A., Saffroy, R., Hamelin, J., Bosselut, N., Lemoine, A.

Get full text

Multidimensional telemonitoring of cancer patients (pts) receiving chronomodulated (chrono) Irinotecan (I), 5-fluorouracil (F), leucovorin (L) and oxaliplatin (O; chronoIFLO4) combination at home by Innominato, P., Komarzynski, S., Bouchahda, M., Ulusakarya, A., Haydar, M., Karaboué, A., Levi, F.

Get full text

1038 OBJECTIVE CORRELATES OF SLEEP COMPLAINT IN CANCER PATIENTS ON CHEMOTHERAPY TELE-MONITORED AT HOME: NIGHT-BY-NIGHT ANALYSIS by Komarzynski, S, Lévi, F, Ballesta, A, Bouchahda, M, Haydar, M, Ulusakarya, A, Morère, J, Innominato, PF

“…Abstract Introduction: Current wrist-actigraphy parameters poorly identify the cancer patients, who subjectively report poor sleep. However, most studies…”
Get full text

Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer by Bouchahda, Mohamed, Boige, Valérie, Smith, Denis, Karaboué, Abdoulaye, Ducreux, Michel, Hebbar, Mohamed, Lepère, Céline, Focan, Christian, Guimbaud, Rosine, Innominato, Pasquale, Awad, Sameh, Carvalho, Carlos, Tumolo, Salvatore, Truant, Stephanie, De Baere, Thierry, Castaing, Denis, Rougier, Philippe, Morère, Jean-François, Taieb, Julien, Adam, René, Lévi, Francis

“…Abstract Background Early tumour shrinkage has been associated with improved survival in patients receiving cetuximab-based systemic chemotherapy for liver…”
Get full text

568P - Safety and Efficacy of Intravenous Cetuximab (CET) and Hepatic Artery Infusion of Irinotecan, 5-Fluorouracil and Oxaliplatin in Patients with Unresectable Liver Metastases from Wt Kras Colorectal Cancer (CRC): Results from Optiliv European Phase II Trial by Levi, F., Boige, V., Rougier, P., Hebbar, M., Smith, D., Focan, C., Guimbaud, R., Carvalho, C., Bouchahda, M., Ducreux, M.

“…Hepatic artery infusion (HAI) of chronomodulated (Chrono) irinotecan (I), 5-Fluorouracil (F) and oxaliplatin (O), or flat O combined with intravenous (iv)…”
Get full text

Safety and Efficacy of Intravenous Cetuximab (CET) and Hepatic Artery Infusion of Irinotecan, 5-Fluorouracil and Oxaliplatin in Patients with Unresectable Liver Metastases from Wt Kras Colorectal Cancer (CRC): Results from Optiliv European Phase II Trial by Levi, F., Boige, V., Rougier, P., Hebbar, M., Smith, D., Focan, C., Guimbaud, R., Carvalho, C., Bouchahda, M., Ducreux, M.

Get full text

1531PDETECTION OF HEALTH-RELATED WARNING SIGNALS THROUGH DAILY TELEMONITORING OF CANCER PATIENTS ON MULTIDRUG CHEMOTHERAPY AT HOME (EUROPEAN PROJECT INCASA) by Arbaud, A., Innominato, P., Mohammad-Djafari, A., Ulusakarya, A., Bossevot-Desmaris, R., Plessis, V., Mocquery, M., Bouchoucha, D., Beau, J., Bouchahda, M., Karaboue, A., Morère, J., Fursse, J., Caprino, M., Levi, F.

“…Abstract Aim: Chemotherapy can be safely administered at home through chronomodulated delivery over the 24 hours via a programmable pump, with improved…”
Get full text

Detection of Health-Related Warning Signals Through Daily Telemonitoring of Cancer Patients on Multidrug Chemotherapy at Home (European Project Incasa) by Arbaud, A., Innominato, P., Mohammad-Djafari, A., Ulusakarya, A., Bossevot-Desmaris, R., Plessis, V., Mocquery, M., Bouchoucha, D., Beau, J., Bouchahda, M., Karaboue, A., Morère, J., Fursse, J., Caprino, M., Levi, F.

Get full text

Integrated management of mother and child health in the region of Monastir (Tunisia)/Prise en charge integree de la sante de la mere et de l'enfant dans la region de Monastir (Tunisie) by El Mhamdi, S, Soltani, M.S, Bouchahda, M, Sriha, A, Bouchahda, I, Bouanene, I

“…The programme of integrated management of child health (IMCI) was established in Tunisia in 2002 in some health districts. This study evaluated the management…”
Get full text

Pharmacokinetic-pharmacodynamic analysis of hepatic artery infusion of three-drug chronomodulated chemotherapy and intravenous cetuximab in patients with liver metastases from colorectal cancer registered in OPTILIV, a European multicenter phase II trial by Levi, F., Karaboué, A., Etienne-Grimaldi, M., Chatelut, E., Innominato, P. F., Paintaud, G., Loukakos, P., Adam, R., Bouchahda, M., Milano, G.

“…Abstract only…”
Get full text